6% Hydroxy-ethyl starch (130/0.4)
GI-CCT24378
Phase 3 small_molecule completed
Quick answer
6% Hydroxy-ethyl starch (130/0.4) for Intensive Care is a Phase 3 program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The George Institute
- Indication
- Intensive Care
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed